Primary Record
Notoginsenoside R1
- In stock
- 7,014 g
- Purity
- 99.2 %
- CAS
- 80418-24-2
Compound Identifiers & Properties
- CAS
- 80418-24-2
- PubChem CID
- 441934
- SMILES
- CC(=CCC[C@@](C)([C@H]1CC[C@@]2([C@@H]1[C@@H](C[C@H]3[C@]2(C[C@@H]([C@@H]4[C@@]3(CC[C@@H](C4(C)C)O)C)O[C@H]5[C@@H]([C@H]([C@@H]([C@H](O5)CO)O)O)O[C@H]6[C@@H]([C@H]([C@@H](CO6)O)O)O)C)O)C)O[C@H]7[C@@H]([C@H]([C@@H]([C@H](O7)CO)O)O)O)C
- Canonical SMILES
- CC(C)=CCC[C@](C)(O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O)[C@H]1CC[C@]2(C)[C@@H]1[C@H](O)C[C@@H]1[C@@]3(C)CC[C@H](O)C(C)(C)[C@@H]3[C@@H](O[C@@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O[C@@H]3OC[C@@H](O)[C@H](O)[C@H]3O)C[C@]12C
Names & Synonyms
- Notoginsenoside R1
- 80418-24-2
- Sanchinoside R1
- Notoginsenoside
- NotoginsenosideR1
- Notoginsenoside R 1
- Pseudolaric acid B
- notoginsenoside-R1
- Sanqi glucoside R1
- (-)-Pseudolaric acid B
- O-Acetylseudolaric acid C
- RefChem:43944
- AC1L9BYK
- (20S)-ginsenoside R1
- MFCD00210535
- NG-R1
- CHEBI:77149
- C47H80O18
- Notoginsenoside R1 (Standard)
- CHEMBL507115
- DTXSID101036451
- orb1304798
- UNII-Z62692362Z
- SCHEMBL28130814
- HSDB 8111
- HY-N0615R
- DTXCID101520638
- HY-N0615
- MSK40040
- Sanchinoside R1;Sanqi glucoside R1
- BBF-05886
- CID441934
- s3785
- Z62692362Z
- AKOS025311471
- ZINC238809173
- ACN-035591
- CCG-270581
- CID:441934
- CS-4167
- Dammarane beta-D-glucopyranoside deriv.
- EBC-221096
- Notoginsenoside R1, >=98% (HPLC)
- Notoginsenoside R1, analytical standard
- ON10463
- C47-H80-O18
- AC-34698
- AN-36396
- BS-17596
- SY068884
- SID:254561560
- AB0019823
- J850.095I
- FT-0630881
- FT-0777167
- N1607
- NOTOGINSENOSIDE R1 (REFERENCE GRADE)
- V0341
- C08961
- (2S,3R,4S,5S,6R)-2-[(2S)-2-[(3S,5R,6S,8R,9R,10R,12R,13R,14R,17S)-6-[(2R,3R,4S,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-3-[(2S,3R,4S,5R)-3,4,5-trihydroxyoxan-2-yl]oxyoxan-2-yl]oxy-3,12-dihydroxy-4,4,8,10,14-pentamethyl-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl]-6-methylhept-5-en-2-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol
- 418N242
- A839906
- C072936
- b-D-Glucopyranoside,(3b,6a,12b)-20-(b-D-glucopyranosyloxy)-3,12-dihydroxydammar-24-en-6-yl 2-O-b-D-xylopyranosyl-
- Q27105065
- beta-D-Glucopyranoside, (3beta,6alpha,12beta)-20-(beta-D-glucopyranosyloxy)-3,12-dihydroxydammar-24-en-6-yl 2-O-beta-D-xylopyranosyl-
- (3|A,6|A,12|A)-20-(|A-D-Glucopyranosyloxy)-3,12-dihydroxydammar-24-en-6-yl 2-O-|A-D-xylopyranosyl-|A-D-glucopyranoside
- Notoginsenoside R1, 98%, from Panax notoginseng (Burk.)F.H.Chen - 5MG 5mg
- (20S)-6alpha-(2-O-beta-D-Xylopyranosyl-beta-D-glucopyranosyloxy)-20-(beta-D-glucopyranosyloxy)-5alpha-dammar-24-ene-3beta,12beta-diol
- (20S)-6alpha-[2-O-(beta-D-Xylopyranosyl)-beta-D-glucopyranosyloxy]-20-(beta-D-glucopyranosyloxy)dammara-24-ene-3beta,12beta-diol
- (2S,3R,4S,5S,6R)-2-(((S)-2-((3S,5R,6S,8R,9R,10R,12R,13R,14R,17S)-6-(((2R,3R,4S,5S,6R)-4,5-Dihydroxy-6-(hydroxymethyl)-3-(((2S,3R,4S,5R)-3,4,5-trihydroxytetrahydro-2H-pyran-2-yl)oxy)tetrahydro-2H-pyran-2-yl)oxy)-3,12-dihydroxy-4,4,8,10,14-pentamethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)-6-methylhept-5-en-2-yl)oxy)-6-(hydroxymethyl)tetrahydro-2H-pyran-3,4,5-triol
- (2S,3R,4S,5S,6R)-2-((1S)-1-((3S,5R,6S,8R,9R,10R,12R,13R,14R,17S)-6-((2R,3R,4S,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-3-((2S,3R,4S,5R)-3,4,5-trihydroxytetrahydropyran-2-yl)oxy-tetrahydropyran-2-yl)oxy-3,12-dihydroxy-4,4,8,10,14-pentamethyl-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1H-cyclopenta(a)phenanthren-17-yl)-1,5-dimethyl-hex-4-enoxy)-6-(hydroxymethyl)tetrahydropyran-3,4,5-triol
- (2S,3R,4S,5S,6R)-2-((2S)-2-((3S,5R,6S,8R,9R,10R,12R,13R,14R,17S)-6-((2R,3R,4S,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-3-((2S,3R,4S,5R)-3,4,5-trihydroxyoxan-2-yl)oxyoxan-2-yl)oxy-3,12-dihydroxy-4,4,8,10,14-pentamethyl-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1H-cyclopenta(a)phenanthren-17-yl)-6-methylhept-5-en-2-yl)oxy-6-(hydroxymethyl)oxane-3,4,5-triol
- (2S,3R,4S,5S,6R)-2-[(1S)-1-[(3S,5R,6S,8R,9R,10R,12R,13R,14R,17S)-6-[(2R,3R,4S,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-3-[(2S,3R,4S,5R)-3,4,5-trihydroxytetrahydropyran-2-yl]oxy-tetrahydropyran-2-yl]oxy-3,12-dihydroxy-4,4,8,10,14-pentamethyl-2,3,5,6,7,9,11,1
- (2S,3R,4S,5S,6R)-2-[(1S)-1-[(3S,5R,6S,8R,9R,10R,12R,13R,14R,17S)-6-[(2R,3R,4S,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-3-[(2S,3R,4S,5R)-3,4,5-trihydroxytetrahydropyran-2-yl]oxy-tetrahydropyran-2-yl]oxy-3,12-dihydroxy-4,4,8,10,14-pentamethyl-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl]-1,5-dimethyl-hex-4-enoxy]-6-(hydroxymethyl)tetrahydropyran-3,4,5-triol
- (2S,3R,4S,5S,6R)-2-{[(2S)-2-[(1S,3aR,3bR,5S,5aR,7S,9aR,9bR,11R,11aR)-5-{[(2R,3R,4S,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-3-{[(2S,3R,4S,5R)-3,4,5-trihydroxyoxan-2-yl]oxy}oxan-2-yl]oxy}-7,11-dihydroxy-3a,3b,6,6,9a-pentamethyl-hexadecahydro-1H-cyclopenta[a]phenanthren-1-yl]-6-methylhept-5-en-2-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol
- (3b,6a,12b)-20-(b-D-Glucopyranosyloxy)-3,12-dihydroxydammar-24-en-6-yl 2-O-b-D-xylopyranosyl-b-D-glucopyranoside
- (3beta,6alpha,12beta)-20-(beta-D-glucopyranosyloxy)-3,12-dihydroxydammar-24-en-6-yl 2-O-beta-D-xylopyranosyl-beta-D-glucopyranoside
- .BETA.-D-GLUCOPYRANOSIDE, (3.BETA.,6.ALPHA.,12.BETA.)-20-(.BETA.-D-GLUCOPYRANOSYLOXY)-3,12-DIHYDROXYDAMMAR-24-EN-6-YL 2-O-.BETA.-D-XYLOPYRANOSYL-
- [20-(beta-D-Glucopyranosyloxy)-3beta,12beta-dihydroxydammar-24-en-6alpha-yl]2-O-(beta-D-xylopyranosyl)-beta-D-glucopyranoside
- 20-(beta-D-Glucopyranosyloxy)-3beta,12beta-dihydroxydammar-24-en-6alpha-yl 2-O-beta-D-xylopyranosyl-beta-D-glucopyranoside
- NOTOGINSENOSIDE R1 (CONSTITUENT OF AMERICAN GINSENG, ASIAN GINSENG, AND TIENCHI GINSENG) [DSC]
- NR1
- ss-D-Glucopyranoside, (3ss,6a,12ss)-20-(ss-D-glucopyranosyloxy)-3,12-dihydroxydammar-24-en-6-yl 2-O-ss-D-xylopyranosyl-; Dammarane, ss-D-glucopyranoside deriv.; (3ss,6a,12ss)-20-(ss-D-Glucopyranosyloxy)-3,12-dihydroxydammar-24-en-6-yl 2-O-ss-D-xylopyranosyl-ss-D-glucopyranoside; Notoginsenoside R1; Sanchinoside R1; Sanqi glucoside R1